Pioneers in the industry, we offer hynidase injection 1500iu, aprecap aprepitant capsules and capegard 500 mg tablets from India.
₹ 144 / Piece Get Latest Price
| Strength | 1500 IU |
| Brand | HINEX |
| Packaging Size | 10 Vials |
| Form | Liquid |
| End Use | Reselling |
| Type of Medicine | Allopathic |
| Composition | Hyaluronidase |
| Country of Origin | Made in India |
We are a trusted B2B supplier and wholesale distributor of Hyaluronidase Injection Samarth in India, offering high-quality injectable formulations for hospitals, clinics, and licensed medical distributors. Samarth Hyaluronidase Injection is manufactured under strict GMP-compliant standards, ensuring safety, sterility, and effective therapeutic performance.
We provide competitive bulk pricing, ready stock availability, and PAN India delivery support for institutional and pharmaceutical buyers.
Product SpecificationsProduct Name: Hyaluronidase Injection Samarth
Generic Name: Hyaluronidase
Dosage Form: Injectable Solution
Strength: 1500 IU / 1 ml (or as per manufacturer specification)
Packaging Type: Vial
Route of Administration: Subcutaneous / Intradermal
Storage Condition: Store below 25°C, protect from light
Category: Enzyme Therapy Injection
Prescription Required: Yes
₹ 899 / Strip Get Latest Price
| Strength | 125 mg |
| Form | Tablet |
| Country of Origin | Made in India |
| Brand | Aprecap |
| Manufactured By | Onkos |
Minimum order quantity: 1 Strip
₹ 400 / Strip Get Latest Price
| Strength | 500 mg |
| Packaging Size | 5 X 10 |
| Packaging Type | Box |
| Brand | CAPEGARD 500 |
| Manufacturer | Cipla |
| Shelf Life | 24 to 36 months |
Generic Name: Capecitabine
Brand Name: Capegard
Strength: 500 mg
Dosage Form: Oral tablet
Capegard 500 mg contains Capecitabine, an oral chemotherapy drug classified as a pyrimidine analog (antimetabolite). It is a prodrug of 5-fluorouracil (5-FU) — meaning it is metabolized in the body into 5-FU, which inhibits DNA synthesis in rapidly dividing cancer cells, leading to cell death.
It offers the convenience of oral administration as an alternative to IV 5-FU.
Indications:Colorectal cancer (adjuvant or metastatic)
Breast cancer (metastatic, especially after failure of other therapies)
Gastric cancer (off-label/combination regimens)
Often used in combination with other agents (e.g., oxaliplatin, docetaxel)
Typically supplied in blister packs of 10 tablets
Export packaging may vary (usually 3 or 10 strips per box)
Oral use only
Usual adult dose: 1250 mg/m² twice daily for 14 days followed by a 7-day rest (cycle-based)
Dosage depends on body surface area (BSA), cancer type, and patient condition
Take within 30 minutes after a meal with water
Store at 15°C to 30°C (room temperature)
Keep in a dry place, away from direct light and moisture
24 to 36 months from the date of manufacture
Capegard is manufactured by Cipla Ltd., a leading Indian pharmaceutical company
Produced in WHO-GMP certified facilities
Prasanna (CEO)
Yarapmin Pharma Private Limited
No D-298, New Market Yard, Station Road, Market Yard
Unjha - 384170, Mahesana, Gujarat, India